These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Hurdles in tissue engineering/regenerative medicine product commercialization: a pilot survey of governmental funding agencies and the financial industry. Bertram TA; Tentoff E; Johnson PC; Tawil B; Van Dyke M; Hellman KB Tissue Eng Part A; 2012 Nov; 18(21-22):2187-94. PubMed ID: 22838399 [TBL] [Abstract][Full Text] [Related]
4. Artificial organ pioneer says Star Wars siphoning funds, creating a brain drain. Kolff WJ Rev Fed Am Health Syst; 1986; 19(4):18, 22-4. PubMed ID: 10280560 [No Abstract] [Full Text] [Related]
5. Tissue engineering: the end of the beginning. Lysaght MJ; Hazlehurst AL Tissue Eng; 2004; 10(1-2):309-20. PubMed ID: 15009955 [TBL] [Abstract][Full Text] [Related]
6. Taking care of business: entrepreneurs share their success stories. Thilmany J; Loughlin S Biomed Instrum Technol; 2010; 44(6):472-3. PubMed ID: 21142509 [No Abstract] [Full Text] [Related]
7. Public and private donor financing for health in developing countries. Howard LM Infect Dis Clin North Am; 1991 Jun; 5(2):221-34. PubMed ID: 1869807 [TBL] [Abstract][Full Text] [Related]
9. The national institute of biomedical imaging and bioengineering and the extramural funding of imaging research. Wallner PE J Am Coll Radiol; 2004 Feb; 1(2):87-8. PubMed ID: 17411531 [No Abstract] [Full Text] [Related]
10. Addressing the decline in NIH pain research funding. Max MB J Pain; 2008 Dec; 9(12):1074-6. PubMed ID: 19038769 [No Abstract] [Full Text] [Related]
11. Great expectations: private sector activity in tissue engineering, regenerative medicine, and stem cell therapeutics. Lysaght MJ; Jaklenec A; Deweerd E Tissue Eng Part A; 2008 Feb; 14(2):305-15. PubMed ID: 18333783 [TBL] [Abstract][Full Text] [Related]
12. Capturing discovery. Dagnone T; Gleeson F Leadersh Health Serv; 1996; 5(3):34-8. PubMed ID: 10158409 [TBL] [Abstract][Full Text] [Related]
13. The coming generation to match the new technology. Aller JC Clin Eng News; 1976 Feb; 4(2):1-5. PubMed ID: 1022390 [No Abstract] [Full Text] [Related]
14. Engineering your own path. Jox R; Gewin V Nature; 2003 Sep; 425(6955):327. PubMed ID: 13679926 [No Abstract] [Full Text] [Related]
15. Venture capital or vulture capital? Knight CJ Life Support Syst; 1983; 1(2):137-40. PubMed ID: 6679010 [No Abstract] [Full Text] [Related]
16. The ARRA investment in CER: a description of the midstream evaluation and how the funds were allocated and CER priorities addressed. Esposito D; Yong PL; Rich E; Geonnotti K; Kimmey LD J Comp Eff Res; 2014 Nov; 3(6):581-9. PubMed ID: 25494564 [TBL] [Abstract][Full Text] [Related]
17. [Biomedical engineering and the public sector]. Chávez-Peón F; Ramírez-Acosta J Gac Med Mex; 1982 Feb; 118(2):58-60. PubMed ID: 7106473 [No Abstract] [Full Text] [Related]
18. Biomedical engineering and the whitaker foundation: a thirty-year partnership. Katona PG Ann Biomed Eng; 2006 Jun; 34(6):904-16. PubMed ID: 16676132 [TBL] [Abstract][Full Text] [Related]
19. Motor vehicle safety, health care, and taxes. National Highway Traffic Safety Administration, U.S. Department of Transportation. Prehosp Disaster Med; 1994; 9(1):11-23. PubMed ID: 10155483 [TBL] [Abstract][Full Text] [Related]
20. Kuwait. United States. Department of State. Bureau of Public Affairs Backgr Notes Ser; 1988 Mar; ():1-8. PubMed ID: 12177972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]